As reported October 29, 2013 in the journal Molecular Therapy, a French research team led by Fabienne Rolling, Ph.D., of INSERM has used gene therapy to restore vision in dogs affected by cone-rod dystrophy. CRD is caused by mutations in the gene RPGRIP1. In this study, retinal cone cell (central vision) function was significantly rescued [Read More]
News
I Can't See What You Mean
by Dan Roberts, Editor-in-Chief Living Well With Low Vision I recently wrote about the challenges people with visual impairment face when listening to speech (“I Can’t See What You’re Saying“, October 4, 2013). In addition to audible confusion, as discussed in that article, our inability to see facial expressions can also cause difficulty understanding implicit [Read More]
B Vitamins: Brain and Eye Health
by Ellen Troyer, MT MA, with Spencer Thornton, MD Evidence continues to mount that links B vitamins deficiency, specifically B6, B12 and folate, to increased risk of developing Macular Degeneration and Alzheimer’s, as well as faster progression of the two disease processes. PLoS One, the open-access journal for the communication of all peer-reviewed scientific and [Read More]
Predictors of Advanced AMD Defined
According to members of the Three Continent AMD Consortium (3CC), prediction models for age-related macular degeneration (AMD) based on case-control studies have a tendency to overestimate risks. To provide more well-defined data, 3CC developed a prediction model for late AMD based on data from population-based studies. Using data from the Rotterdam Study, the Beaver Dam [Read More]
Riding the AMD Roller Coaster
Why do we see on some days worse than on others? by Dan Roberts Editor-in-Chief, Low Vision Resources Gradual vision loss is to be expected with age-related macular degeneration (AMD). Even though it is expected, however, slow deterioration of our view of the world can cause fear, depression, and chronic stress in those of us [Read More]